Antipsychotic Agents (administration & dosage) < Antipsychotic Agents (adverse effects) < Antipsychotic Agents (classification)

Facettes :

List of bibliographic references indexed by Antipsychotic Agents (adverse effects)

Number of relevant bibliographic references: 87.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
001357 (2011)	Maria Sierra Pe A [États-Unis] ; Toby C. Yaltho [États-Unis] ; Joseph Jankovic [États-Unis]	Tardive dyskinesia and other movement disorders secondary to aripiprazole
001684 (2011)	Richard A. Walsh [Canada] ; Anthony E. Lang [Canada]	Early‐onset tardive dyskinesia in a neuroleptic‐naive patient exposed to low‐dose quetiapine
001688 (2011)	Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]	Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France
001694 (2011)	Kirsten R. Müller-Vahl [Allemagne] ; Deborah Krueger [Allemagne]	Does Tourette syndrome prevent tardive dyskinesia?
001A29 (2010)	Caspar Stephani [Allemagne] ; Claudia Trenkwalder [Allemagne]	Rhabdomyolysis after low‐dose quetiapine in a patient with Parkinson's disease with drug‐induced psychosis: A case report
001A30 (2010)	Mohammed T. Ahmad [Singapour] ; Kumar M. Prakash [Singapour]	Reversible hyperkinetic movement disorder associated with quetiapine withdrawal
001B57 (2010)	P. Ken Gillman [Australie]	Neuroleptic malignant syndrome: Mechanisms, interactions, and causality
001B58 (2010)	Maximilian Gahr [Allemagne] ; Michael Orth [Allemagne] ; Birgit Abler [Allemagne]	Neuroleptic malignant syndrome with aripiprazole in Huntington's disease
001D03 (2010)	Lior Greenbaum [Israël] ; Anna Alkelai [Israël] ; Amihai Rigbi [Israël] ; Yoav Kohn [Israël] ; Bernard Lerer [Israël]	Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia
002086 (2009)	Silva Link [Allemagne] ; Walter Paulus [Allemagne] ; Borwin Bandelow [Allemagne]	Remission of acute psychotic anxious depression in a patient with Parkinson's disease after treatment with quetiapine
002208 (2009)	Sebastian Paus [Allemagne] ; Franziska Gadow [Allemagne] ; Michael Knapp [Allemagne] ; Christine Klein [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]	Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism
002232 (2009)	Hae-Won Shin [Corée du Sud] ; Mi J. Kim [Corée du Sud] ; Jong S. Kim [Corée du Sud] ; Myoung C. Lee [Corée du Sud] ; Sun J. Chung [Corée du Sud]	Levosulpiride‐induced movement disorders
002441 (2009)	David D. Dore [États-Unis] ; Amal N. Trivedi [États-Unis] ; Vincent Mor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Kate L. Lapane [États-Unis]	Atypical antipsychotic use and risk of fracture in persons with Parkinsonism
002645 (2008)	Marcel J. H. Aries [Belgique] ; Hans Debruyne [Belgique] ; Sebastiaan Engelborghs [Belgique] ; Nathalie Le Bastard [Belgique] ; Nore Somers [Belgique] ; Dagmar Gorissen [Belgique] ; Barbara A. Pickut [Belgique] ; Peter Paul De Deyn [Belgique]	Reversal of head drop after discontinuation of olanzapine in a DLB patient
002848 (2008)	Christine D. Esper [Géorgie (pays)] ; Stewart A. Factor [Géorgie (pays)]	Failure of recognition of drug‐induced parkinsonism in the elderly
002B46 (2007)	Ikwunga Wonodi [États-Unis] ; Gloria Reeves [États-Unis] ; Dana Carmichael [États-Unis] ; Ilene Verovsky [États-Unis] ; Matthew T. Avila [États-Unis] ; Amie Elliott [États-Unis] ; L. Elliot Hong [États-Unis] ; Helene M. Adami [États-Unis] ; Gunvant K. Thaker [États-Unis]	Tardive dyskinesia in children treated with atypical antipsychotic medications
003157 (2006)	Hortensia Alonso-Navarro [Espagne] ; Félix Javier Jiménez-Jiménez [Espagne]	Tardive blepharospasm beginning after withdrawal of veralipride
003275 (2006)	Ken-Ichi Harada [Japon]	Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease: A case report
003360 (2006)	Spiros Konitsiotis [Grèce] ; Sofia Pappa [Grèce] ; Christos Mantas [Grèce] ; Venos Mavreas [Grèce]	Levetiracetam in tardive dyskinesia: An open label study
003420 (2006)	Katie Kompoliti [États-Unis] ; Christopher G. Goetz [États-Unis] ; Mary Morrissey [États-Unis] ; Sue Leurgans [États-Unis]	Gilles de la Tourette syndrome: Patient's knowledge and concern of adverse effects
003447 (2006)	Daniel Tarsy [États-Unis] ; Ross J. Baldessarini [États-Unis]	Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antipsychotic Agents (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antipsychotic Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antipsychotic Agents (adverse effects)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024